CureVac N.V. (Nasdaq: CVAC), a pioneering multinational biotech company developing a new class of transformative medicines based on messenger RNA (mRNA), today announced the voting results of the Comp...
BioGrafie: (Stuttgart/Tübingen) – Annette Widmann-Mauz used to be Member of the Bundestag (Germany’s Parliament) for Tübingen and part of the Christian Democrat Union (CDU) parliamentary group. She wa...
Acquisition will strengthen the research, development, manufacturing and commercialization of mRNA-based cancer immunotherapy candidates, marking BioNTech’s next key mile...
On June 4 and 5, 2025, we had the opportunity to participate in two outstanding events that focused on the innovative SME sector in Germany and highlighted the central ro...
(Stuttgart/Reutlingen) – Dr. Severino Urban and Dr. Stefan Frey founded Oralgenix GmbH in Reutlingen Technology Park in 2025. Using molecular biological analyses of the m...
Stafford, Texas and Tuebingen, Germany, May 31, 2025 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company active in the...
TÜBINGEN, Germany/BOSTON, USA – May 15, 2025CureVac N.V. (Nasdaq: CVAC) (“CureVac”), a global biotech company developing a new class of transformative medicines based on...
Houston, Texas and Tuebingen, Germany, May 13, 2025 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company active in the ...
05/13/2025
| Council of European BioRegions (CEBR)
The Council of European BioRegions (CEBR), the leading network of life science clusters across Europe, is pleased to announce the results of its 2025–2026 Board Elections...
On May 9, 2025, representatives from the life sciences industry in North Carolina and Baden-Württemberg met in Stuttgart for professional exchange. The goal of the event was to explore opportunities f...
Researchers at the University of Stuttgart have used microbial processes to produce environmentally friendly bio-concrete from urine as part of a “wastewater-bio-concrete-fertilizer” value chain. With the project extension granted by the Baden-W...
Tuebingen, Germany, April 15, 2025 – HepaRegeniX GmbH (“HepaRegeniX”), a clinical-stage company advancing novel therapies to treat acute and chronic liver diseases, today...
(Stuttgart/Reutlingen) – The “Digital Integration and Innovation in Surgery” (Digitale Integration und Innovation in der Chirurgie, DIIC) project aims to promote the transfer of new findings and resea...
On April 4, 2025, BioRegio STERN Management GmbH, together with VOELKER & Partner Attorneys, Auditors, and Tax Advisors mbB, hosted an interactive seminar in Stuttgar...
CureVac N.V. (Nasdaq: CVAC) (“CureVac”), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”...
(Stuttgart) – BioRegio STERN Management GmbH is the lead partner responsible for the new STEP4NAMs project (Step up the use for new approach methodologies to replace anim...
Researchers led by Dr. Michael Pawlak from NMI Technologie Transfer GmbH (NMI TT) in Reutlingen and Prof. Dr. Hans Neubauer from the Women's Hospital at the University of...
On February 25 and 26, 2024, the official kick-off meeting of the STEP4NAMs project took place in Stuttgart. Our international consortium of ten partners gathered to set the course for promoting New A...
(Stuttgart/Reutlingen) – Michael Kaiser, Managing Director of Wirtschaftsförderung Region Stuttgart GmbH (WRS), was unanimously elected the new Chair of the Supervisory Board of BioRegio STERN Managem...
(Stuttgart) – BioRegio STERN Management GmbH is a German partner in the European NAMWISE (New Approach Methodologies Within Integrated Safety & Efficacy evaluation of chemicals and pharmaceuticals...
